Product Platforms - Thursday 15 November 2018

Please note, these sessions are not CPD-accredited.

11:15 - 11:30
Novo Nordisk
Novo Nordisk Logo

Ozempic® (semaglutide) a once-weekly GLP-1 RA receptor agonist

Attend this session to find out more about Ozempic, a once-weekly glucagon-like peptide 1 receptor agonist indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus.

Regional Medical Advisor, Novo Nordisk UK
11:35 - 11:50
Roche Logo

OurPath Digital Lifestyle Intervention Programme

OurPath – an NHS Healthier You DPP supplier of choice, has a Trust Pilot score of 9.8 out of 10. Come along to hear from a digital lifestyle coach why it’s so highly rated by those who have been through the programme

Anna Cummings
Digital Coach
Roche Diabetes Care
11:50 - 13:10


13:10 - 13:25
Dexcom Logo

Dexcom G6 Continuous Glucose Monitoring System

Discover the Dexcom G6, the first real-time diabetes management system approved with Zero fingersticks.

Benjamin Byrne
National Sales Manager, Dexcom
14:05 - 14:20
Changing Health

Empowering patients to improve glycaemic control through lifestyle support

Learn how Changing Health’s Transform results in a 20% decrease in hospitalisations for Type 2 diabetes and a 20% increase in medication, by supporting patients to sustain positive lifestyle habits and reduce their HbA1c. Built on nine years of behavioural science research, the programme combines evidence-based digital education on diabetes with ongoing support from a…

CEO & Vice President, Changing Health, Diabetes UK
14:20 - 15:30


15:30 - 15:45
Napp Pharmaceuticals
Napp Diabetes Logo

Effective Prescribing in Diabetes (EPID) – a collaborative medicines optimisation project in North Central London

As we consider the initiation of newer medical therapies for people with type 2 diabetes, it is equally important to review the repeat prescribing of older anti-glycaemic agents initiated in the past. A collaborative project in North Central London developed an audit tool and template to help identify and review patients with sub-optimal glycemic control,…

Dr Amrit Lamba
Diabetes GPwSI, Barnet CCG
11:15 - 11:30

Product Demonstration

1. Inform and update on a removable offloading device. 2. Review the NICE National Guideline on Offloading. 3. Share clinical cases of the use of VASOcast Diabetic. 4. Look at the challenges of not offloading the Diabetic foot.

Clinical Lead for Podiatry, Solent NHS Trust
11:45 - 12:00

Prevention of DFU’s GlucoRx Allpresan- An ideal Moisturiser for your Diabetic Patients

A healthy skin barrier is crucial to protect against mechanical, microbial and chemical damage. If skin is abnormally dry, fissures can develop, the skin loses its elasticity, flexibility and ability to withstand trauma, resulting in skin breakdown and subsequent infection. Dry skin on a diabetic foot is one of the risk factors for foot ulcer…

Tim Dowdall
Healthcare Partnership Manager, DMS, MSc, BSc Hons (Pharmacy)
12:00 - 13:10


14:05 - 14:20
Flexitol Logo

Early detection and costs of diabetic foot complications

How daily foot inspection and the application of urea-based emollients can lead to the early detection of foot complications associated with Diabetes; Comparison of the costs associated with urea-based emollient use vs. diabetes related lower-limb amputation and diabetic foot ulcer management.

Donna Welch
Principal Podiatrist - Diabetes, Humber NHS Foundation Trust
14:20 - 15:30


11:15 - 11:30
Metabolic Health Solutions Logo

Where Does The Fat Go?

Weight loss is a key aim in the treatment of Type 2 diabetes. It is generally accepted that to lose weight, a person needs to burn more energy than consumed. To lose weight in a healthy way, it is important to burn fat and not glucose. How do you know what your patient’s energy expenditure…

Peter Robins
General Manager, Europe, Metabolic Health Solutions
11:50 - 13:10


13:10 - 13:25
My Way Digital Health (MWDH)
My Way Digital Health Logo

Diabetes Management Solutions for Patients and Professionals

This presentation will demonstrate information technology systems that can be used to effectively underpin diabetes services for patients and professionals. It will demonstrate experiences from within the NHS in Scotland, and how services are now being rolled out in other parts of the UK through MyWay Digital Health. The presentation will show the benefits of…

Dr Scott Cunningham
Chief Technical Officer, My Way Digital Health

Please note, these sessions are not CPD-accredited.

If you have agreed to receive communications from our sponsors using the DPC2018 registration form and you attend a product platform, you may be contacted by the product platform organisation directly.

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families